Jubilant Radiopharma would like to wish all of our colleagues, customers and partners in the U.S. a safe and happy Fourth of July! #JubliantRadiopharma #IndependenceDay #FourthofJuly #DiagnosticImaging #NuclearMedicine
Jubilant Radiopharma’s Post
More Relevant Posts
-
Today we started using Vabysmo for RVO! I believe in using the most potent and durable agents for my patients and using dual inhibition to address RVO is a step forward for our field given the improved macular leakage in patients treated with Vabysmo vs Aflibercrpt 2mg in the pivotal BALATON and COMINO trials. For any new drug and new indication, real world data is important to establish efficacy, safety and durability. We all need to work together to generate the real world data for Vabysmo in RVO! #Vabysmo #RVO #clinicalresearch #clinicaltrials
To view or add a comment, sign in
-
-
Treating conditions that cause blindness irreversible without care. Educate the patient on taking proper care to avoid early morbidity from preventable complications of diabetes & AMD. Engage tpatient in their health
I believe in ANG2 block but with the recent Eylea HD approval for all indications how do we reconcile similar results without ANG2 block. Regeneron explains that the binding of their molecule for VEGF A is superior to Vabysmo so that is why ANG2 block is needed in Vabysmo and not necessary in Eylea HD. No need for ANG2 block because ofAflipercept better molecule for VEGF A
Today we started using Vabysmo for RVO! I believe in using the most potent and durable agents for my patients and using dual inhibition to address RVO is a step forward for our field given the improved macular leakage in patients treated with Vabysmo vs Aflibercrpt 2mg in the pivotal BALATON and COMINO trials. For any new drug and new indication, real world data is important to establish efficacy, safety and durability. We all need to work together to generate the real world data for Vabysmo in RVO! #Vabysmo #RVO #clinicalresearch #clinicaltrials
To view or add a comment, sign in
-
-
Sometimes all it takes is a moment of WAIT: Words, Action, Intervention, Together. 💚 If you or someone you know is struggling, remember that help is always available. #SuicidePrevention #YouAreNotAlone #WorldSuicidePreventionDay #IndusPharmaOfficial #IndusPharma #IndusGroup
To view or add a comment, sign in
-
-
One potential solution to AMR is the development of new, more effective antibiotics to replace those which become more resistant. Unfortunately, this is not happening. As SCIENCE writes "...without government intervention, R&D for antibiotics is rarely profitable, and most major pharmaceutical companies have left the field"[17]. The economics of antibiotic discovery and development are further complicated as it, "depends on various factors: which drug and pathogen are involved, the mechanism of antibiotic resistance, the prevalence of that pathogen, the types of infections it causes and their level of transmissibility, the health burden of those infections, and whether alternative treatments are available"[17]. The challenges of misuse (usually over-prescription, but sometimes under-prescription) of antibiotics, particularly in the realm of RTIs, alongside the considerable hurdles in antibiotic research and development present an extremely difficult challenge for global healthcare to address. Visit the Senzo website to request the full report... #AMR #AntimicrobialResistance #Superbugs #PostAntibioticEra #AntibioticStewardship #InfectionControl #GlobalHealth #AMRActionFund #Diagnostics #NewAntibiotics #InfectiousDiseases #DrugResistance #Healthcare #PublicHealth #Medicine #Pharma #Biotech #IDWeek #ASMmicrobe #ICAAC #ECCMID #microbiology
To view or add a comment, sign in
-
A big step towards achieving the goal of being the best Medical Communication company.
We're thrilled to announce that Cactus Life Sciences has acquired nspm ltd and eluSCIdate! nspm's rare disease expertise and global event proficiency expand Cactus Life Sciences' services amidst their exciting buy-and-build strategy. This collaboration marks a significant advancement in services for our biopharma clients with a comprehensive global approach to medical communications. "Cactus Life Sciences stands out for its unwavering commitment to excellence, innovation, and future-readiness,” remarked Elvira Dsouza, President. https://hubs.ly/Q02tWJ2T0 #medcomm #medaffairs #pharma #scicomm #lifesciences
To view or add a comment, sign in
-
The paucity of new antibiotics hitting the market is clear. "A rapid decrease in the number of new drugs approved and numerous withdrawals on quality and safety grounds" are pivotal factors contributing to the shrinking reservoir of effective antibiotics [16]. Due to this, as written in the British Medical Journal, "the existing classes of antibiotics are probably the best we will ever have."[16] Visit the Senzo website to request the full report... #AMR #AntimicrobialResistance #Superbugs #PostAntibioticEra #AntibioticStewardship #InfectionControl #GlobalHealth #AMRActionFund #Diagnostics #NewAntibiotics #InfectiousDiseases #DrugResistance #Healthcare #PublicHealth #Medicine #Pharma #Biotech #IDWeek #ASMmicrobe #ICAAC #ECCMID #microbiology
SENZO
senzo.com
To view or add a comment, sign in
-
A standing ovation is in order, folks! We've hit the astronomical milestone of #1000followers! To all you incredibly generous souls who decided to grace us with your presence, you truly are the bomb – no, really! We are #grateful for every connection that shares our passion for #closingthegap between patients and their treatments - #meetingtheunmet. Our journey has been defined by providing #high-quality, #non-availablemedicines for #orphan and #low-prevalencediseases, either because the product is not yet sold in their country, does not have #marketingauthorization, has been #discontinued or it is in #shortsupply. But for real, we need to give a big thank you to each member of our #growingcommunity for your #support in our objective to build long-term relationships based on #trust. Here's to the next chapter of innovation and collaboration! Let’s keep growing and making connections together. #meetingtheunmet #raredisease #namedpatient #patientscomefirst #healthsystemsstrengthening #healthissues #pharmaindustry #pharmabusiness #pharma #shortages #drugshortages #medicineshortage #accesstomedicine #orphandisease #pharmasupplychain #pharmadistribution #pharmalogistics #pharmaceuticalsupply #pharmalogisticsanddistribution #healthforall #1KFollowers #Thankyou #onethousand #onethousandfollowers
To view or add a comment, sign in
-
-
Sales expert with a passion to achieve global healthcare transformation | Patient Centricity | Data & Software | Artificial intelligence | Business Development, Growth , leadership & management
🌟 Day 1 of #ECO24 was mind-blowing! 🧠 Understanding how the brain's functions impact appetite and combatting obesity is 🔑! We need a multi-faceted approach to tackle weight loss, and teamwork among healthcare professionals is 💪! With new medical advancements, collaboration is 🔝of the list. 👩⚕️ DocNexus links you with 8.5M+ healthcare professionals to fight obesity effectively. If you're at #ECO24, let's chat about shaping a healthier tomorrow together! 💼👨⚕️ #Pharma #ObesityTreatment Currax Pharmaceuticals LLC Boehringer Ingelheim Eli Lilly and Company Novo Nordisk
To view or add a comment, sign in
-
-
2 CAR-T approvals in just 24 hours! 𝐀𝐛𝐞𝐜𝐦𝐚 𝐚𝐧𝐝 𝐂𝐚𝐫𝐯𝐲𝐤𝐭𝐢 𝐁𝐎𝐓𝐇 𝐫𝐞𝐜𝐞𝐢𝐯𝐞𝐝 𝐅𝐃𝐀 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥𝐬 on Friday. Wow. ➡️ These are expanded approvals. Carvykti by Johnson & Johnson and Legend Biotech, and Abecma by Bristol-Myers Squibb and 2seventy bio, have both gained FDA approval for multiple myeloma treatment. Carvykti can now be used after one prior therapy, expanding CAR-T therapy to earlier lines of treatment. Abecma's approval allows it to be used as a third-line therapy, marking a shift towards earlier use in the treatment pathway. Amazing that Q2 is starting strong and great to see 4/13 approvals are secured. With 9 more 'anticipated approvals' in the next 8 months, it's an incredibly exciting time for patients who are on the brink of receiving the treatment they need. P.S. I still need to work on improving my graphic design markup skills! 😄 #celltherapy #genetherapy #biotech #CGTweekly
To view or add a comment, sign in
-
-
The paucity of new antibiotics hitting the market is clear. "A rapid decrease in the number of new drugs approved and numerous withdrawals on quality and safety grounds" are pivotal factors contributing to the shrinking reservoir of effective antibiotics [16]. Due to this, as written in the British Medical Journal, "the existing classes of antibiotics are probably the best we will ever have."[16] Visit the Senzo website to request the full report... #AMR #AntimicrobialResistance #Superbugs #PostAntibioticEra #AntibioticStewardship #InfectionControl #GlobalHealth #AMRActionFund #Diagnostics #NewAntibiotics #InfectiousDiseases #DrugResistance #Healthcare #PublicHealth #Medicine #Pharma #Biotech #IDWeek #ASMmicrobe #ICAAC #ECCMID #microbiology
SENZO
senzo.com
To view or add a comment, sign in